Global Anti-infectious Disease Drugs Market Growth 2025-2031

March 2025 | 125 pages | ID: G9DF753C8E17EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Anti-infectious Disease Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Anti-infectious Disease Drugs Industry Forecast” looks at past sales and reviews total world Anti-infectious Disease Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-infectious Disease Drugs sales for 2025 through 2031. With Anti-infectious Disease Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-infectious Disease Drugs industry.

This Insight Report provides a comprehensive analysis of the global Anti-infectious Disease Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-infectious Disease Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-infectious Disease Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-infectious Disease Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-infectious Disease Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-infectious Disease Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Antibacterial Drugs
• Antifungal Drugs
• Antiviral Drugs
• Antiparasitic Drugs

Segmentation by Application:

• Hospital
• Institute of Medicine
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Aridis Pharmaceuticals
• AiCuris
• Sandoz
• Anhui Jingfang Medical Industry Co.,Ltd
• Beijing Double-Crane Pharmaceutical Co., Ltd.
• Abbott
• Spero Therapeutics
• Adlyfe, Inc.
• Advanced Life Sciences Holdings, Inc.
• Affinium Pharmaceuticals
• APP Pharmaceuticals
• Aquapharm Biodiscovery
• Basilea Pharmaceutica AG
• Biophage Pharma, Inc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Anti-infectious Disease Drugs market?

What factors are driving Anti-infectious Disease Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Anti-infectious Disease Drugs market opportunities vary by end market size?

How does Anti-infectious Disease Drugs break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Anti-infectious Disease Drugs Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Anti-infectious Disease Drugs by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Anti-infectious Disease Drugs by Country/Region, 2020, 2024 & 2031
2.2 Anti-infectious Disease Drugs Segment by Type
  2.2.1 Antibacterial Drugs
  2.2.2 Antifungal Drugs
  2.2.3 Antiviral Drugs
  2.2.4 Antiparasitic Drugs
2.3 Anti-infectious Disease Drugs Sales by Type
  2.3.1 Global Anti-infectious Disease Drugs Sales Market Share by Type (2020-2025)
  2.3.2 Global Anti-infectious Disease Drugs Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Anti-infectious Disease Drugs Sale Price by Type (2020-2025)
2.4 Anti-infectious Disease Drugs Segment by Application
  2.4.1 Hospital
  2.4.2 Institute of Medicine
  2.4.3 Clinic
  2.4.4 Others
2.5 Anti-infectious Disease Drugs Sales by Application
  2.5.1 Global Anti-infectious Disease Drugs Sale Market Share by Application (2020-2025)
  2.5.2 Global Anti-infectious Disease Drugs Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Anti-infectious Disease Drugs Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Anti-infectious Disease Drugs Breakdown Data by Company
  3.1.1 Global Anti-infectious Disease Drugs Annual Sales by Company (2020-2025)
  3.1.2 Global Anti-infectious Disease Drugs Sales Market Share by Company (2020-2025)
3.2 Global Anti-infectious Disease Drugs Annual Revenue by Company (2020-2025)
  3.2.1 Global Anti-infectious Disease Drugs Revenue by Company (2020-2025)
  3.2.2 Global Anti-infectious Disease Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Anti-infectious Disease Drugs Sale Price by Company
3.4 Key Manufacturers Anti-infectious Disease Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Anti-infectious Disease Drugs Product Location Distribution
  3.4.2 Players Anti-infectious Disease Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ANTI-INFECTIOUS DISEASE DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Anti-infectious Disease Drugs Market Size by Geographic Region (2020-2025)
  4.1.1 Global Anti-infectious Disease Drugs Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Anti-infectious Disease Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Anti-infectious Disease Drugs Market Size by Country/Region (2020-2025)
  4.2.1 Global Anti-infectious Disease Drugs Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Anti-infectious Disease Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-infectious Disease Drugs Sales Growth
4.4 APAC Anti-infectious Disease Drugs Sales Growth
4.5 Europe Anti-infectious Disease Drugs Sales Growth
4.6 Middle East & Africa Anti-infectious Disease Drugs Sales Growth

5 AMERICAS

5.1 Americas Anti-infectious Disease Drugs Sales by Country
  5.1.1 Americas Anti-infectious Disease Drugs Sales by Country (2020-2025)
  5.1.2 Americas Anti-infectious Disease Drugs Revenue by Country (2020-2025)
5.2 Americas Anti-infectious Disease Drugs Sales by Type (2020-2025)
5.3 Americas Anti-infectious Disease Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Anti-infectious Disease Drugs Sales by Region
  6.1.1 APAC Anti-infectious Disease Drugs Sales by Region (2020-2025)
  6.1.2 APAC Anti-infectious Disease Drugs Revenue by Region (2020-2025)
6.2 APAC Anti-infectious Disease Drugs Sales by Type (2020-2025)
6.3 APAC Anti-infectious Disease Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Anti-infectious Disease Drugs by Country
  7.1.1 Europe Anti-infectious Disease Drugs Sales by Country (2020-2025)
  7.1.2 Europe Anti-infectious Disease Drugs Revenue by Country (2020-2025)
7.2 Europe Anti-infectious Disease Drugs Sales by Type (2020-2025)
7.3 Europe Anti-infectious Disease Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Anti-infectious Disease Drugs by Country
  8.1.1 Middle East & Africa Anti-infectious Disease Drugs Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Anti-infectious Disease Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Anti-infectious Disease Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Anti-infectious Disease Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-infectious Disease Drugs
10.3 Manufacturing Process Analysis of Anti-infectious Disease Drugs
10.4 Industry Chain Structure of Anti-infectious Disease Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Anti-infectious Disease Drugs Distributors
11.3 Anti-infectious Disease Drugs Customer

12 WORLD FORECAST REVIEW FOR ANTI-INFECTIOUS DISEASE DRUGS BY GEOGRAPHIC REGION

12.1 Global Anti-infectious Disease Drugs Market Size Forecast by Region
  12.1.1 Global Anti-infectious Disease Drugs Forecast by Region (2026-2031)
  12.1.2 Global Anti-infectious Disease Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Anti-infectious Disease Drugs Forecast by Type (2026-2031)
12.7 Global Anti-infectious Disease Drugs Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Aridis Pharmaceuticals
  13.1.1 Aridis Pharmaceuticals Company Information
  13.1.2 Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Portfolios and Specifications
  13.1.3 Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Aridis Pharmaceuticals Main Business Overview
  13.1.5 Aridis Pharmaceuticals Latest Developments
13.2 AiCuris
  13.2.1 AiCuris Company Information
  13.2.2 AiCuris Anti-infectious Disease Drugs Product Portfolios and Specifications
  13.2.3 AiCuris Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 AiCuris Main Business Overview
  13.2.5 AiCuris Latest Developments
13.3 Sandoz
  13.3.1 Sandoz Company Information
  13.3.2 Sandoz Anti-infectious Disease Drugs Product Portfolios and Specifications
  13.3.3 Sandoz Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Sandoz Main Business Overview
  13.3.5 Sandoz Latest Developments
13.4 Anhui Jingfang Medical Industry Co.,Ltd
  13.4.1 Anhui Jingfang Medical Industry Co.,Ltd Company Information
  13.4.2 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Portfolios and Specifications
  13.4.3 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Anhui Jingfang Medical Industry Co.,Ltd Main Business Overview
  13.4.5 Anhui Jingfang Medical Industry Co.,Ltd Latest Developments
13.5 Beijing Double-Crane Pharmaceutical Co., Ltd.
  13.5.1 Beijing Double-Crane Pharmaceutical Co., Ltd. Company Information
  13.5.2 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Portfolios and Specifications
  13.5.3 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Beijing Double-Crane Pharmaceutical Co., Ltd. Main Business Overview
  13.5.5 Beijing Double-Crane Pharmaceutical Co., Ltd. Latest Developments
13.6 Abbott
  13.6.1 Abbott Company Information
  13.6.2 Abbott Anti-infectious Disease Drugs Product Portfolios and Specifications
  13.6.3 Abbott Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Abbott Main Business Overview
  13.6.5 Abbott Latest Developments
13.7 Spero Therapeutics
  13.7.1 Spero Therapeutics Company Information
  13.7.2 Spero Therapeutics Anti-infectious Disease Drugs Product Portfolios and Specifications
  13.7.3 Spero Therapeutics Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Spero Therapeutics Main Business Overview
  13.7.5 Spero Therapeutics Latest Developments
13.8 Adlyfe, Inc.
  13.8.1 Adlyfe, Inc. Company Information
  13.8.2 Adlyfe, Inc. Anti-infectious Disease Drugs Product Portfolios and Specifications
  13.8.3 Adlyfe, Inc. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Adlyfe, Inc. Main Business Overview
  13.8.5 Adlyfe, Inc. Latest Developments
13.9 Advanced Life Sciences Holdings, Inc.
  13.9.1 Advanced Life Sciences Holdings, Inc. Company Information
  13.9.2 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Portfolios and Specifications
  13.9.3 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Advanced Life Sciences Holdings, Inc. Main Business Overview
  13.9.5 Advanced Life Sciences Holdings, Inc. Latest Developments
13.10 Affinium Pharmaceuticals
  13.10.1 Affinium Pharmaceuticals Company Information
  13.10.2 Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Portfolios and Specifications
  13.10.3 Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Affinium Pharmaceuticals Main Business Overview
  13.10.5 Affinium Pharmaceuticals Latest Developments
13.11 APP Pharmaceuticals
  13.11.1 APP Pharmaceuticals Company Information
  13.11.2 APP Pharmaceuticals Anti-infectious Disease Drugs Product Portfolios and Specifications
  13.11.3 APP Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 APP Pharmaceuticals Main Business Overview
  13.11.5 APP Pharmaceuticals Latest Developments
13.12 Aquapharm Biodiscovery
  13.12.1 Aquapharm Biodiscovery Company Information
  13.12.2 Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Portfolios and Specifications
  13.12.3 Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Aquapharm Biodiscovery Main Business Overview
  13.12.5 Aquapharm Biodiscovery Latest Developments
13.13 Basilea Pharmaceutica AG
  13.13.1 Basilea Pharmaceutica AG Company Information
  13.13.2 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Portfolios and Specifications
  13.13.3 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 Basilea Pharmaceutica AG Main Business Overview
  13.13.5 Basilea Pharmaceutica AG Latest Developments
13.14 Biophage Pharma, Inc.
  13.14.1 Biophage Pharma, Inc. Company Information
  13.14.2 Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Portfolios and Specifications
  13.14.3 Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.14.4 Biophage Pharma, Inc. Main Business Overview
  13.14.5 Biophage Pharma, Inc. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Anti-infectious Disease Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Anti-infectious Disease Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Antibacterial Drugs
Table 4. Major Players of Antifungal Drugs
Table 5. Major Players of Antiviral Drugs
Table 6. Major Players of Antiparasitic Drugs
Table 7. Global Anti-infectious Disease Drugs Sales byType (2020-2025) & (K Units)
Table 8. Global Anti-infectious Disease Drugs Sales Market Share byType (2020-2025)
Table 9. Global Anti-infectious Disease Drugs Revenue byType (2020-2025) & ($ million)
Table 10. Global Anti-infectious Disease Drugs Revenue Market Share byType (2020-2025)
Table 11. Global Anti-infectious Disease Drugs Sale Price byType (2020-2025) & (US$/Unit)
Table 12. Global Anti-infectious Disease Drugs Sale by Application (2020-2025) & (K Units)
Table 13. Global Anti-infectious Disease Drugs Sale Market Share by Application (2020-2025)
Table 14. Global Anti-infectious Disease Drugs Revenue by Application (2020-2025) & ($ million)
Table 15. Global Anti-infectious Disease Drugs Revenue Market Share by Application (2020-2025)
Table 16. Global Anti-infectious Disease Drugs Sale Price by Application (2020-2025) & (US$/Unit)
Table 17. Global Anti-infectious Disease Drugs Sales by Company (2020-2025) & (K Units)
Table 18. Global Anti-infectious Disease Drugs Sales Market Share by Company (2020-2025)
Table 19. Global Anti-infectious Disease Drugs Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Anti-infectious Disease Drugs Revenue Market Share by Company (2020-2025)
Table 21. Global Anti-infectious Disease Drugs Sale Price by Company (2020-2025) & (US$/Unit)
Table 22. Key Manufacturers Anti-infectious Disease Drugs Producing Area Distribution and Sales Area
Table 23. Players Anti-infectious Disease Drugs Products Offered
Table 24. Anti-infectious Disease Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Anti-infectious Disease Drugs Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Anti-infectious Disease Drugs Sales Market Share Geographic Region (2020-2025)
Table 29. Global Anti-infectious Disease Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Anti-infectious Disease Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Anti-infectious Disease Drugs Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Anti-infectious Disease Drugs Sales Market Share by Country/Region (2020-2025)
Table 33. Global Anti-infectious Disease Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Anti-infectious Disease Drugs Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Anti-infectious Disease Drugs Sales by Country (2020-2025) & (K Units)
Table 36. Americas Anti-infectious Disease Drugs Sales Market Share by Country (2020-2025)
Table 37. Americas Anti-infectious Disease Drugs Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Anti-infectious Disease Drugs Sales byType (2020-2025) & (K Units)
Table 39. Americas Anti-infectious Disease Drugs Sales by Application (2020-2025) & (K Units)
Table 40. APAC Anti-infectious Disease Drugs Sales by Region (2020-2025) & (K Units)
Table 41. APAC Anti-infectious Disease Drugs Sales Market Share by Region (2020-2025)
Table 42. APAC Anti-infectious Disease Drugs Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Anti-infectious Disease Drugs Sales byType (2020-2025) & (K Units)
Table 44. APAC Anti-infectious Disease Drugs Sales by Application (2020-2025) & (K Units)
Table 45. Europe Anti-infectious Disease Drugs Sales by Country (2020-2025) & (K Units)
Table 46. Europe Anti-infectious Disease Drugs Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Anti-infectious Disease Drugs Sales byType (2020-2025) & (K Units)
Table 48. Europe Anti-infectious Disease Drugs Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Anti-infectious Disease Drugs Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Anti-infectious Disease Drugs Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Anti-infectious Disease Drugs Sales byType (2020-2025) & (K Units)
Table 52. Middle East & Africa Anti-infectious Disease Drugs Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Anti-infectious Disease Drugs
Table 54. Key Market Challenges & Risks of Anti-infectious Disease Drugs
Table 55. Key IndustryTrends of Anti-infectious Disease Drugs
Table 56. Anti-infectious Disease Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Anti-infectious Disease Drugs Distributors List
Table 59. Anti-infectious Disease Drugs Customer List
Table 60. Global Anti-infectious Disease Drugs SalesForecast by Region (2026-2031) & (K Units)
Table 61. Global Anti-infectious Disease Drugs RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Anti-infectious Disease Drugs SalesForecast by Country (2026-2031) & (K Units)
Table 63. Americas Anti-infectious Disease Drugs Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Anti-infectious Disease Drugs SalesForecast by Region (2026-2031) & (K Units)
Table 65. APAC Anti-infectious Disease Drugs Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Anti-infectious Disease Drugs SalesForecast by Country (2026-2031) & (K Units)
Table 67. Europe Anti-infectious Disease Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Anti-infectious Disease Drugs SalesForecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Anti-infectious Disease Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Anti-infectious Disease Drugs SalesForecast byType (2026-2031) & (K Units)
Table 71. Global Anti-infectious Disease Drugs RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Anti-infectious Disease Drugs SalesForecast by Application (2026-2031) & (K Units)
Table 73. Global Anti-infectious Disease Drugs RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Aridis Pharmaceuticals Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 76. Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 77. Aridis Pharmaceuticals Main Business
Table 78. Aridis Pharmaceuticals Latest Developments
Table 79. AiCuris Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. AiCuris Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 81. AiCuris Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 82. AiCuris Main Business
Table 83. AiCuris Latest Developments
Table 84. Sandoz Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Sandoz Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 86. Sandoz Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 87. Sandoz Main Business
Table 88. Sandoz Latest Developments
Table 89. Anhui Jingfang Medical Industry Co.,Ltd Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 91. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 92. Anhui Jingfang Medical Industry Co.,Ltd Main Business
Table 93. Anhui Jingfang Medical Industry Co.,Ltd Latest Developments
Table 94. Beijing Double-Crane Pharmaceutical Co., Ltd. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 96. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 97. Beijing Double-Crane Pharmaceutical Co., Ltd. Main Business
Table 98. Beijing Double-Crane Pharmaceutical Co., Ltd. Latest Developments
Table 99. Abbott Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Abbott Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 101. Abbott Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 102. Abbott Main Business
Table 103. Abbott Latest Developments
Table 104. SperoTherapeutics Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. SperoTherapeutics Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 106. SperoTherapeutics Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 107. SperoTherapeutics Main Business
Table 108. SperoTherapeutics Latest Developments
Table 109. Adlyfe, Inc. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Adlyfe, Inc. Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 111. Adlyfe, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 112. Adlyfe, Inc. Main Business
Table 113. Adlyfe, Inc. Latest Developments
Table 114. Advanced Life Sciences Holdings, Inc. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 116. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 117. Advanced Life Sciences Holdings, Inc. Main Business
Table 118. Advanced Life Sciences Holdings, Inc. Latest Developments
Table 119. Affinium Pharmaceuticals Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 121. Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 122. Affinium Pharmaceuticals Main Business
Table 123. Affinium Pharmaceuticals Latest Developments
Table 124. APP Pharmaceuticals Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. APP Pharmaceuticals Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 126. APP Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 127. APP Pharmaceuticals Main Business
Table 128. APP Pharmaceuticals Latest Developments
Table 129. Aquapharm Biodiscovery Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 131. Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 132. Aquapharm Biodiscovery Main Business
Table 133. Aquapharm Biodiscovery Latest Developments
Table 134. Basilea Pharmaceutica AG Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 136. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 137. Basilea Pharmaceutica AG Main Business
Table 138. Basilea Pharmaceutica AG Latest Developments
Table 139. Biophage Pharma, Inc. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 141. Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 142. Biophage Pharma, Inc. Main Business
Table 143. Biophage Pharma, Inc. Latest Developments



LIST OFFIGURES

Figure 1. Picture of Anti-infectious Disease Drugs
Figure 2. Anti-infectious Disease Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-infectious Disease Drugs Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Anti-infectious Disease Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Anti-infectious Disease Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Anti-infectious Disease Drugs Sales Market Share by Country/Region (2024)
Figure 10. Anti-infectious Disease Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Antibacterial Drugs
Figure 12. Product Picture of Antifungal Drugs
Figure 13. Product Picture of Antiviral Drugs
Figure 14. Product Picture of Antiparasitic Drugs
Figure 15. Global Anti-infectious Disease Drugs Sales Market Share byType in 2025
Figure 16. Global Anti-infectious Disease Drugs Revenue Market Share byType (2020-2025)
Figure 17. Anti-infectious Disease Drugs Consumed in Hospital
Figure 18. Global Anti-infectious Disease Drugs Market: Hospital (2020-2025) & (K Units)
Figure 19. Anti-infectious Disease Drugs Consumed in Institute of Medicine
Figure 20. Global Anti-infectious Disease Drugs Market: Institute of Medicine (2020-2025) & (K Units)
Figure 21. Anti-infectious Disease Drugs Consumed in Clinic
Figure 22. Global Anti-infectious Disease Drugs Market: Clinic (2020-2025) & (K Units)
Figure 23. Anti-infectious Disease Drugs Consumed in Others
Figure 24. Global Anti-infectious Disease Drugs Market: Others (2020-2025) & (K Units)
Figure 25. Global Anti-infectious Disease Drugs Sale Market Share by Application (2024)
Figure 26. Global Anti-infectious Disease Drugs Revenue Market Share by Application in 2025
Figure 27. Anti-infectious Disease Drugs Sales by Company in 2025 (K Units)
Figure 28. Global Anti-infectious Disease Drugs Sales Market Share by Company in 2025
Figure 29. Anti-infectious Disease Drugs Revenue by Company in 2025 ($ millions)
Figure 30. Global Anti-infectious Disease Drugs Revenue Market Share by Company in 2025
Figure 31. Global Anti-infectious Disease Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Anti-infectious Disease Drugs Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Anti-infectious Disease Drugs Sales 2020-2025 (K Units)
Figure 34. Americas Anti-infectious Disease Drugs Revenue 2020-2025 ($ millions)
Figure 35. APAC Anti-infectious Disease Drugs Sales 2020-2025 (K Units)
Figure 36. APAC Anti-infectious Disease Drugs Revenue 2020-2025 ($ millions)
Figure 37. Europe Anti-infectious Disease Drugs Sales 2020-2025 (K Units)
Figure 38. Europe Anti-infectious Disease Drugs Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Anti-infectious Disease Drugs Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Anti-infectious Disease Drugs Revenue 2020-2025 ($ millions)
Figure 41. Americas Anti-infectious Disease Drugs Sales Market Share by Country in 2025
Figure 42. Americas Anti-infectious Disease Drugs Revenue Market Share by Country (2020-2025)
Figure 43. Americas Anti-infectious Disease Drugs Sales Market Share byType (2020-2025)
Figure 44. Americas Anti-infectious Disease Drugs Sales Market Share by Application (2020-2025)
Figure 45. United States Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Anti-infectious Disease Drugs Sales Market Share by Region in 2025
Figure 50. APAC Anti-infectious Disease Drugs Revenue Market Share by Region (2020-2025)
Figure 51. APAC Anti-infectious Disease Drugs Sales Market Share byType (2020-2025)
Figure 52. APAC Anti-infectious Disease Drugs Sales Market Share by Application (2020-2025)
Figure 53. China Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. India Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. ChinaTaiwan Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Anti-infectious Disease Drugs Sales Market Share by Country in 2025
Figure 61. Europe Anti-infectious Disease Drugs Revenue Market Share by Country (2020-2025)
Figure 62. Europe Anti-infectious Disease Drugs Sales Market Share byType (2020-2025)
Figure 63. Europe Anti-infectious Disease Drugs Sales Market Share by Application (2020-2025)
Figure 64. Germany Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65.France Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share byType (2020-2025)
Figure 71. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share by Application (2020-2025)
Figure 72. Egypt Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75.Turkey Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Anti-infectious Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Anti-infectious Disease Drugs in 2025
Figure 78. Manufacturing Process Analysis of Anti-infectious Disease Drugs
Figure 79. Industry Chain Structure of Anti-infectious Disease Drugs
Figure 80. Channels of Distribution
Figure 81. Global Anti-infectious Disease Drugs Sales MarketForecast by Region (2026-2031)
Figure 82. Global Anti-infectious Disease Drugs Revenue Market ShareForecast by Region (2026-2031)
Figure 83. Global Anti-infectious Disease Drugs Sales Market ShareForecast byType (2026-2031)
Figure 84. Global Anti-infectious Disease Drugs Revenue Market ShareForecast byType (2026-2031)
Figure 85. Global Anti-infectious Disease Drugs Sales Market ShareForecast by Application (2026-2031)
Figure 86. Global Anti-infectious Disease Drugs Revenue Market ShareForecast by Application (2026-2031)